Teva Pharmaceutical Industries Limited American Depositary Shares

TEVANYSEUSD
35.38 USD
3.76 (11.89%)AT CLOSE (11:59 AM EDT)
35.21
0.18 (0.50%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
35.21
0.18 (0.50%)
🔴Market: CLOSED
Open?$34.00
High?$35.62
Low?$33.92
Prev. Close?$31.62
Volume?22.3M
Avg. Volume?5.5M
VWAP?$34.96
Rel. Volume?4.04x
Bid / Ask
Bid?$34.75 × 100
Ask?$35.51 × 500
Spread?$0.76
Midpoint?$35.13
Valuation & Ratios
Market Cap?36.8B
Shares Out?1.2B
P/E Ratio?26.13
P/B Ratio?4.65
EPS?$1.21
Dividend?0.92%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.06Adequate
Quick Ratio?0.82Weak
Cash Ratio?0.27Low
Debt/Equity?2.12High
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
26.1FAIR
P/B?
4.65FAIR
P/S?
2.13CHEAP
P/FCF?
32.1FAIR
EV/EBITDA?
10.1CHEAP
EV/Sales?
2.90CHEAP
Returns & Efficiency
ROE?
17.8%STRONG
ROA?
3.5%FAIR
Cash Flow & Enterprise
FCF?$1.1B
Enterprise Value?$50.1B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Employees
32.8K
Market Cap
36.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1982-02-16
Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
TEL AVIV,
Phone: 972 (3) 914-8213